인쇄하기
취소

Kwangdong/Finechem trying a joint R&D for new bulk drugs.

Published: 2006-01-16 06:59:00
Updated: 2006-01-16 06:59:00
Kwangdong agreed with Finechem, a bio venture company of Korea, on Jan. 10 for the local production of new bulk drugs.

Under the agreement, Kwangdong takes responsibilities for the dosage studies, stability tests, safety tests and health registration in the commercialization stage whereas Finechem for the synthesis of bulk drugs, establishment of specification for the health registration and...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.